Compound 1568
Identifiers
- Canonical SMILES:
CS(=O)(=O)c1ccc(CN(Cc2cccc(CNS(=O)(=O)c3cc(Cl)cc(Cl)c3O)c2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1
- InChi:
InChI=1S/C28H24Cl4N2O8S3/c1-43(37,38)22-7-5-17(6-8-22)15-34(45(41,42)26-13-21(30)11-24(32)28(26)36)16-19-4-2-3-18(9-19)14-33-44(39,40)25-12-20(29)10-23(31)27(25)35/h2-13,33,35-36H,14-16H2,1H3
- InChiKey:
JAHXXYBXDOSNTN-UHFFFAOYSA-N
External links
![]() 66616620 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 56 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.83 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 751.94 g/mol | |||
HBA | 10 | |||
HBD | 3 | |||
HBA + HBD | 13 | |||
AlogP | 5.68 | |||
TPSA | 158.15 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 56 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.83 | |
WO2009152082 | 56 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.73 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6415 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4790 | Saccharin | DB12418 | |
0.4706 | Sulfabenzamide | DB09355 | |
0.4615 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4540 | Evatanepag | DB12022 | |
0.4430 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4375 | N-Benzyl-4-Sulfamoyl-Benzamide | DB01748 | |
0.4336 | AL5927 | DB03526 | |
0.4215 | N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02069 | |
0.4202 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.4154 | UK-390957 | DB11719 | |
0.4146 | N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide | DB03844 | |
0.4128 | CGS-27023 | DB07556 | |
0.4110 | N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE | DB04588 | |
0.4091 | {4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID | DB07999 |